(Q44261692)

English

Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Intracellular concentration of protease inhibitors in HIV-1-infected patients: correlation with MDR-1 gene expression and low dose of ritonavir (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1 reference

based on heuristic

inferred from title

author name string

Chaillou S

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Durant J

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Garraffo R

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Georgenthum E

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Roptin C

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clevenbergh P

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Dunais B

7

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Mondain V

8

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Roger PM

9

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Dellamonica P

10

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

HIV Clinical Trials

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

493-501

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

P-glycoproteins and multidrug resistance

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Human immunodeficiency virus I-induced expression of P-glycoprotein

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Intracellular accumulation of human immunodeficiency virus protease inhibitors

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Role of P-glycoprotein on the CNS disposition of amprenavir (141W94), an HIV protease inhibitor.

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

St Johns wort increases expression of P-glycoprotein: implications for drug interactions

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Comparison of solutol HS 15, Cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Abnormal expression of a 170-kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures.

1 reference

https://api.crossref.org/works/10.1310%2F0873-BVDP-AKAY-445U

21 January 2018

Identifiers

10.1310/0873-BVDP-AKAY-445U

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44261692&oldid=2108973010"